On 13 February 2018
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 13 February 2018, consider and approve the unaudited financial results along with the Limited Review Report for the quarter ended 31st December, 2017, and any other matter with the permission of the Chair.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
